On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
40° Feels Like: 33°
Wind: WNW 13 mph Past 24 hrs - Precip: 0.26”
Current Radar for Zip

Tonight

Rain 37°

Tomorrow

PM Showers 58°

Sat Night

Partly Cloudy 31°

Alerts

ThromboGenics acquires rights to eye treatment technology

BRUSSELS (Reuters) - Belgian biopharmaceutical company ThromboGenics said on Thursday it had entered into an agreement with British peer Bicycle Therapeutics to develop and launch new drugs to treat opthalmic diseases.

ThromboGenics said it would seek to use Bicycle's peptides, tiny particles which could be used to treat diabetic macular edema, a leading cause of vision loss in adults, particularly those with diabetes.

ThromboGenics, which specializes in eye treatment, will pay Bicycle an undisclosed upfront fee and payments related to development and regulatory milestones.

(Reporting By Philip Blenkinsop)

Comments